Close Menu

Trovagene

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Trovagene today said it has completed its acquisition of the CLIA laboratory of MultiGen Diagnostics.

TrovaGene said this week that it has obtained an exclusive worldwide license for mutations of the SF3B1 splicing factor that are associated with disease progression and chemotherapy response in chronic lymphocytic leukemia.

PrimeraDx this week announced that it has appointed Leroy Hood to its scientific advisory board.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – TrovaGene today said that it has licensed exclusive worldwide rights to assay technology for the detection of hairy cell leukemia.

By Monica Heger
This story, originally published Aug. 11, has been updated to include comments from TrovaGene co-founder Gabriele Cerrone.

Canon, Philipps-Universität Marburg, Johns Hopkins University, Brandeis University, Samsung, City of Hope, Amplion, and Trovagene are awarded US patents.

US patents awarded to LLNL, TrovaGene, Rockefeller U, Gen-Probe, Human Genetic Signatures, Riken, DNAForm, U of Utah, Idaho Tech, Rubicon, Cepheid, Toshiba, Chang Gung University, Samsung, Apodemus, and Robert-Koch Institut.

Pages

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.